Company Filing History:
Years Active: 2010-2014
Title: John F Darbyshire: Innovator in TRPV1 Antagonists
Introduction
John F Darbyshire is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit TRPV1. With a total of 2 patents, his work has implications for treating various medical conditions.
Latest Patents
Darbyshire's latest patents focus on compounds that inhibit TRPV1, specifically compounds of formula (I) wherein R, R, and L are defined in the description. These TRPV1 antagonists exhibit low inhibitory activity against CYP3A4. The patents also disclose compositions comprising such compounds and methods for treating conditions and disorders using these compounds and compositions.
Career Highlights
Throughout his career, John F Darbyshire has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His expertise in drug development has positioned him as a valuable asset in the field.
Collaborations
Darbyshire has collaborated with notable professionals in his field, including Chih-hung Lee and Richard J Perner. These collaborations have further enhanced his research and development efforts.
Conclusion
John F Darbyshire's innovative work in the development of TRPV1 antagonists showcases his commitment to advancing medical science. His contributions continue to influence the pharmaceutical landscape and offer potential solutions for various health conditions.